Showing results (1931-1940 of 2,150) with videos related to

Sort By:
Pageof 215
Scientific Reports|February 27, 2024
Optimal cutoff value of the dry eye-related quality-of-life score for diagnosing dry eye diseaseXinrong Zou, Ken Nagino, Yuichi Okumura, et al.
Pediatric Surgery International|November 4, 2010
Pediatric patients receiving ABO-incompatible living related liver transplantation exhibit higher serum transforming growth factor-β1, interferon-γ and interleukin-2 levelsMohamed Hamed Hussein, Takashi Hashimoto, Ghada AbdEl-Hamid Daoud, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 1, 2004
Novel insertional mutation in the bone morphogenetic protein receptor type II associated with sporadic primary pulmonary hypertensionShoko Sugiyama, Hisao Hirota, Maki Yoshida, et al.
The Journal of Dermatology|December 27, 2018
Rituximab therapy for refractory autoimmune bullous diseases: A multicenter, open-label, single-arm, phase 1/2 study on 10 Japanese patientsYuichi Kurihara, Jun Yamagami, Takeru Funakoshi, et al.
Journal of Cell Science|December 5, 2018
The Robo4-TRAF7 complex suppresses endothelial hyperpermeability in inflammationKeisuke Shirakura, Ryosuke Ishiba, Taito Kashio, et al.
Communications Biology|July 22, 2022
Upregulation of OASIS/CREB3L1 in podocytes contributes to the disturbance of kidney homeostasisYoshiaki Miyake, Masanori Obana, Ayaha Yamamoto, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 12, 2005
Glycogen debranching enzyme association with beta-subunit regulates AMP-activated protein kinase activityHideyuki Sakoda, Midori Fujishiro, Junko Fujio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Antisense to cyclin D1 inhibits vascular endothelial growth factor-stimulated growth of vascular endothelial cells: implication of tumor vascularizationMasayoshi Yasui, Hirofumi Yamamoto, Chew Yee Ngan, et al.
Anticancer Research|May 4, 2005
A combination phase I study of weekly paclitaxel and doxifluridine in advanced gastric cancer patientsIzumi Takeyoshi, Fujio Makita, Yoshifumi Tanahashi, et al.
Pageof 215